National Parkinson Foundation
12
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
25.0%
3 terminated/withdrawn out of 12 trials
72.7%
-13.8% vs industry average
8%
1 trials in Phase 3/4
25%
2 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Parkinson's Foundation Quality Improvement Initiative
Role: lead
Light Therapy Treatment in Parkinson's Disease Patients With Daytime Somnolence
Role: collaborator
Mindfulness-based Cognitive Therapy (MBCT) for People With Parkinson's Disease
Role: collaborator
Exercise Targeting Cognitive Impairment in Parkinson's Disease
Role: collaborator
Connect.Parkinson: Connecting Individuals With Parkinson Disease to Specialists in Their Homes
Role: collaborator
Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease
Role: collaborator
Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
Role: collaborator
Cognitive Behavioral Therapy for Depression in Parkinson's Disease
Role: collaborator
WiiMote Game Controller as a Device to Study Movement Disorders
Role: collaborator
Mood and Subthalamic Nucleus (STN) Deep Brain Stimulation
Role: collaborator
Reduction of Falls in the Elderly - Parkinson's Disease
Role: collaborator
A Pilot, Randomized Controlled Trial of Group Visits for Persons With Parkinson's Disease
Role: collaborator
All 12 trials loaded